Oncology Institute (TOIIW) Assets Average (2020 - 2026)

Oncology Institute has reported Assets Average for 7 years, with the latest figure at $166.4 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 1.14% year-over-year to $166.4 million; the trailing twelve-month figure through Mar 2026 stood at $166.4 million (down 1.14% YoY), and the FY2025 full-year result was $168.7 million, down 11.67% from the prior year.
• Assets Average for Q1 2026 stood at $166.4 million, up from $164.1 million in the prior quarter.
• The five-year high for Assets Average was $272.7 million in Q4 2022, with the low at $161.7 million in Q3 2025.
• Historically, Assets Average has averaged $200.5 million across 5 years, with a median of $198.1 million in 2022.
• Annual changes were most pronounced in 2022 — Assets Average soared 38.16% — and 2023, when it slipped 21.61%.
• Oncology Institute's Assets Average stood at $272.7 million in 2022, then declined by 21.61% to $213.8 million in 2023, then fell by 17.7% to $176.0 million in 2024, then retreated by 6.71% to $164.1 million in 2025, then grew by 1.4% to $166.4 million in 2026.
• The last three Assets Average figures came in at $166.4 million (Q1 2026), $164.1 million (Q4 2025), and $161.7 million (Q3 2025), per Business Quant data.